MYC and prostate carcinoma: Moreover, previous metabolic profiling performed by our group on MYC engineered prostate cells, in vivo models, and human prostate cancers showed that MYC overexpression specifically enhances lipid metabolism underlying lipid deregulation as key metabolic feature of MYC oncogenic activity in prostate cancer26.